These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1150 related items for PubMed ID: 14635068

  • 21. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
    Poulos CK, Daggy JK, Cheng L.
    Cancer; 2004 Aug 01; 101(3):527-32. PubMed ID: 15274065
    [Abstract] [Full Text] [Related]

  • 22. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
    Potters L, Purrazzella R, Brustein S, Fearn P, Leibel SA, Kattan MW.
    Cancer; 2002 Oct 01; 95(7):1451-6. PubMed ID: 12237913
    [Abstract] [Full Text] [Related]

  • 23. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 24. Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.
    Freedland SJ, Partin AW, Epstein JI, Walsh PC.
    Cancer; 2004 Apr 15; 100(8):1646-9. PubMed ID: 15073852
    [Abstract] [Full Text] [Related]

  • 25. Is there a difference in outcome after radical prostatectomy between patients with biopsy Gleason sums 4, 5, and 6? Results from the SEARCH database.
    Freedland SJ, Amling CL, Terris MK, Presti JC, Aronson WJ, Elashoff D, Kane CJ, SEARCH Database Study Group.
    Prostate Cancer Prostatic Dis; 2003 Apr 15; 6(3):261-5. PubMed ID: 12970733
    [Abstract] [Full Text] [Related]

  • 26. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL.
    BJU Int; 2012 Jul 15; 110(1):36-42. PubMed ID: 22085203
    [Abstract] [Full Text] [Related]

  • 27. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
    Bastian PJ, Gonzalgo ML, Aronson WJ, Terris MK, Kane CJ, Amling CL, Presti JC, Mangold LA, Humphreys E, Epstein JI, Partin AW, Freedland SJ.
    Cancer; 2006 Sep 15; 107(6):1265-72. PubMed ID: 16900523
    [Abstract] [Full Text] [Related]

  • 28. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
    Makarov DV, Sanderson H, Partin AW, Epstein JI.
    J Urol; 2002 Jun 15; 167(6):2440-2. PubMed ID: 11992053
    [Abstract] [Full Text] [Related]

  • 29. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM, Babaian K, Cheung MR, Naya Y, Huang SH, Kuban D, Babaian RJ.
    J Urol; 2003 Nov 15; 170(5):1860-3. PubMed ID: 14532793
    [Abstract] [Full Text] [Related]

  • 30. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2001 Jul 15; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [Abstract] [Full Text] [Related]

  • 31. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.
    Freedland SJ, Aronson WJ, Csathy GS, Kane CJ, Amling CL, Presti JC, Dorey F, Terris MK, SEARCH Database Study Group.
    Urology; 2003 Apr 15; 61(4):742-7. PubMed ID: 12670558
    [Abstract] [Full Text] [Related]

  • 32. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
    de la Taille A, Rubin MA, Bagiella E, Olsson CA, Buttyan R, Burchardt T, Knight C, O'Toole KM, Katz AE.
    J Urol; 1999 Jul 15; 162(1):103-6. PubMed ID: 10379750
    [Abstract] [Full Text] [Related]

  • 33. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O.
    J Urol; 2007 Nov 15; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [Abstract] [Full Text] [Related]

  • 34. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
    Scales CD, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ, SEARCH Database Study Group.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1249-52. PubMed ID: 17698131
    [Abstract] [Full Text] [Related]

  • 35. Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy.
    Guzzo TJ, Vira MA, Neway W, Hwang WT, Tomaszewski J, VanArsdalen K, Wein AJ, Malkowicz SB.
    Urology; 2007 Jun 15; 69(6):1147-51. PubMed ID: 17572204
    [Abstract] [Full Text] [Related]

  • 36. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy.
    Kausik SJ, Blute ML, Sebo TJ, Leibovich BC, Bergstralh EJ, Slezak J, Zincke H.
    Cancer; 2002 Sep 15; 95(6):1215-9. PubMed ID: 12216087
    [Abstract] [Full Text] [Related]

  • 37. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M, Hayasaka S, Taylor JM, Shah R, Proverbs-Singh T, Manley S, Rubin MA.
    J Urol; 2001 Dec 15; 166(6):2193-7. PubMed ID: 11696734
    [Abstract] [Full Text] [Related]

  • 38. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy.
    Patel DA, Presti JC, McNeal JE, Gill H, Brooks JD, King CR.
    J Clin Oncol; 2005 Sep 01; 23(25):6157-62. PubMed ID: 16135482
    [Abstract] [Full Text] [Related]

  • 39. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
    Tareen B, Godoy G, Sankin A, Temkin S, Lepor H, Taneja SS.
    BJU Int; 2009 Jul 01; 104(2):195-9. PubMed ID: 19191784
    [Abstract] [Full Text] [Related]

  • 40. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
    Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL.
    Eur Urol; 2008 Apr 01; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.